2009 4th Medical Biotech Forum
Theme: Translating Bio-Innovations into Industrialization
Time: Aug. 8-10, 2009
Venue: Dalian, China

 Aug. 8, 2009 (Saturday)
 Opening Ceremony and Keynote Forum

 Time

 Activities

 Aug. 8, 2009 (Saturday)  
 9:00-17:00

 Opening Ceremony &Keynote Forum

 Main topics

 Title: New Drug Innovation and Development Strategies and Major Measures in China
 Dr. Guowei Sang, Academician and CTO, Special group of major science and technology in general, China

 Title: Biotechnology in Medicine
 Dr. Zhu Chen, Academician, Ministry of Health, China

 Title: Drug Policies and Essential Drugs Management in China
 Officer from the department of the drugs policy and basic drug system, Ministry of Health, China

 Title: The Registration and Management of New Biotechnology Products Officer from the department of  
 registration, State food and drug administration, China

 Title: Global Comparison of China Medical Technology and Industrial Competitiveness
 Mr. Hongguang Wang, Director, China Biotechnology Development Center, the Ministry of Science and  
 Technology of China

 Title: Medical Biotechnology and Appropriate Technology
 Dr. Depei Liu, Academician, Chinese academy of medical sciences, China

 Title: The Development of Biopharmaceuticals and Bioindustry in China .
 Dr. Zhinan Chen, Academician, The Fourth Military Medical University, China

 Title: The Strategy and Policy of Chinese Bio-indursty  Officer from National Development and Reform  
 Commission, China

 Title: The Effect and Opportunity of Independent Innovation and Biomedical Industry under the International  
 Economic Situation in China
 Mr. Duojia Feng, deputy general manager, Bitechnology corporation of China.

 Title: The Development and Risk Investment of Biotechnology in China
 Mr. Gang Lin, Chairman, Shenzhen Kangzhe Pharmaceutical Co., ltd, China

 Session Chair:

 Dr. Jason (Gang) Jin, CEO, ShanghaiBio Corporation (SBC for Global R&D Services
 in USA), China

 Title: Genomics Applications in Personal Medicine and Biomarker Studies
 Dr. Jason (Gang) Jin, CEO, ShanghaiBio Corporation (SBC for Global R&D Services  in USA), China

 Title: Methods to Link Functional Genomics Data and Classical Descriptors of  
 Pathogenesis to Guide Target and Biomarker Search
 Dr. Endre Laczko, Functional Genomic Center, UZH / ETHZ Switzerland

 Title: Advances in medicine accomplished by serial analysis of gene expression.
 Dr. Jonny St-Amand, Professor, University Laval;Director, Functional Genomics  
 Laboratory,Molecular Endocrinology and Oncology Research Center,Quebec Genome  
 Center, Laval University Medical Center (CHUL), Canada

 Title: Beyond Sequencing: What We Do with Huge Piles of Sequence Data?
 Dr. Kuo Ping Chiu, Associate Research Fellow, GRC, Academia Sinica, Taiwan

 Session Chair:

 Dr. Wayne Carter, Nottingham, United Kingdom, UK

 Title: Physiological Plasticity of Royal Jelly Proteins as a Consequence of  
 Posttranslational Modification –  Assumption for Application in Medicine
 Dr. Katarina Bilikova, Dpt. of Molecular Apidolology, Institute of Molecular Biology,  
 Slovak Academy of Sciences, Slovakia

 Title: Protein Interaction Forces Studied with Single-Molecule Manipulation
 Dr. Ching-Hwa Kiang, Assistant Professor, Physics & Astronomy, Rice University,  
 USA

 Title: Protein Kinase A: Possible Role in Depression and Therapeutic Intervention
 Dr. Yogesh Dwivedi, Associate Professor of Pharmacology and Psychiatry,  
 Department of Psychiatry, University of Illinois at Chicago, USA

 Session Chair:

 Dr. Ramon Cacabelos, Professor and Chairman, EuroEspes Biomedical Research  
 Center, Institute for CNS Disorders, Spain

 Title: Contribution of Population-based Genetic Studies to Drug Discovery
 Dr. Vincent Mooser, VP Head Applied Genetics, GlaxoSmithkline, USA

 Title: Genomic Medicine and Pharmacogenetics in Brain Disorders
 Dr. Ramon Cacabelos, Professor and Chairman, EuroEspes Biomedical Research  
 Center, Institute for CNS Disorders, Spain

 Title: Laforin in Neuron Stress Resistance
 Dr. Yan Liu, Assistant Professor, Department of Surgery, University of Michigan, USA

 Title: Anti-Tuberculosis Chemotherapy: Targeting Cell Wall Arabinan
 Dr. Delphi Chatterjee, Professor, Department of Microbiology, Immunology and  
 Pathology, Colorado State University, USA

 Session Chair:

 Dr. Jun Wang, Associate Director, Beijing Genomics Institute Shenzhen, China

 Title: Cancer and Viral/RetroViral Immunotherapy by Selective Stimulation of  
 Proliferation of Natural Killer Cells and Quantitative “Omics-Phenotyping” by Novel
 Nano-Bio-Devices for Diagnosis, Prognosis and Monitoring Purposes
 Dr. Gradimir Misevic, CEO, Gimmune GmbH, Switzerland

 Title: The 1000 Genomes Project
 Dr. Jun Wang, Associate Director, Beijing Genomics Institute Shenzhen, China

 Title: Unraveling the Functional Interactions in Cell Macromolecular Networks, and  
 Searching for Protein-targeted Small Lead Compounds, Using Fitness-based  
 Interferential Genetics (FIG)
 Dr. Jacques Daniel, Charge de Recherche，Centre National de la Recherche  
 Scientifique, France

 Title: Sensitized Genome-wide ENU Mutagenesis: A Functional Genomic Approach to  
 Identify Novel Modified Genes of Sox10 Neurocristopathy
 Dr. Ling Hou, Wenzhou Medical College/NHGRI, NIH, USA

 Session Chair:

 Dr. Shuiping Jiang, British Heart Foundation Fellow, Department of Nephrology and  
 Transplantation, Guy's Hospital, King's College London, UK

 Title: TBD
 Dr. Scott Kahn, VP and Chief Information Officer, Illumina Inc., USA

 Title: Regulatory T Cells as Individualised Medicine for Autoimmune Disease and  
 Trannsplantation Tolerance
 Dr. Shuiping Jiang, British Heart Foundation Fellow, Department of Nephrology and  
 Transplantation, Guy's Hospital, King's College London, UK

 Title: Genome-Wide Associations, Energy Balance, and Obesity
 Dr. Lu Qi, assistant professor and associate epidemiologist, Harvard Medical School  
 and Harvard School of Public Health, USA

 Title: TBD
 Dr. Sean X. Hu, Partner (Principal) Candidate, Leader, Personalized Medicine  
 Strategy Consulting, IMS Management Consulting, IMS Health, USA

 Title: the ACE Genotype and its Relevance in the Pathogenesis of Cardiovascular  
 Disaese and Treatment
 Dr. Gert Mayer, Head, Department of Internal Medicine IV (Nephrology and  
 Hypertension), Medical University Innsbruck, Austria

 15:10-15:30

 Title: Newer Insights in to the Neuroprotective Propensity of Bacopa Monneri in  
 Prepubertal Mice
 Dr. Muralidhara, Deputy Director, Biochemistry & Nutrition Dept., Central Food  
 Technological Research Institute, India

 Session Chair:

 Dr. Lin Wu, Director, Genomics and Oncology Department, Roche Molecular Systems,
 Inc., USA

 Title: From Bench to Bedside: Anti-IFN-a Antibody Potential in Rheumatic Diseases
 Dr. Bahija Jallal, Global head of Research and VP of Translational Sciences,  
 MedImmune, Inc., USA

 Title: From Drug Target to Patient Selection: Opportunities and Challenges of  
 Developing Companion Diagnostic Test in Clinical Drug Development
 Dr. Lin Wu, Director, Genomics and Oncology Department, Roche Molecular Systems,  Inc., USA

 Title: Translational Medicine: an Industry Perspective
 Dr. Anfan Wu, Sr. Director, Experimental Clinical Pharmacology, Early Drug
 Development, Celgene Corp. USA

 Title: Interleukin-6 in Surgery and Critical Care: Basic Science and Clinical Applications
 Dr. Randeep Jawa, Assistant Professor, University of Nebraska Medical Center,
 United States of America，USA

 Session Chair:

 Dr. C. S. Chen, Adjunct Professor, National Tsing Hua University; Adjunct Professor, 
 National Dong Hwa University; Advisor, Industrial Technology Research Institute,  
 Taiwan

 Title: Novel Nanowire Biosensors for Kawasaki Disease Diagnosis
 Dr. Deli Wang, Assistant Professor, Department of Electrical and Computer  
 Engineering, University of California, USA

 Title: Manipulation and Analysis of Single DNA Molecules and Self-assembled Lipid  
 Nanotubes
 Dr. Ken Hirano, Health Technology Research Center, National Institute of Advanced  
 Industrial Science and Technology (AIST), Japan

 Title: Activity and Conformation from Saturation Adsorptions of Lysozyme on Silica and  Diamond Nanoparticles
 Dr. Victor Wei-Keh Wu, Assistant Professor, 1. Dept. Chem. and Materials Eng.  
 National Kaohsiung Univ. of Appl. Sciences, Kaohsiung, Taiwan 2. Inst. of Atomic and  
 Molecular Sci. Taiwan 3. Victor Basic Research Laboratory, Germany

 Title: Nanobiotechnology and Biomimetics
 Dr. C. S. Chen, Adjunct Professor, National Tsing Hua University; Adjunct Professor, 
 National Dong Hwa University; Advisor, Industrial Technology Research Institute,
 Taiwan

 Title: Parameters Governing Gold Nanoparticle X-ray Radiosensitization
 Dr. Cécile Sicard-Roselli, Associate. Professor , Laboratoire de Chimie Physique,  
 Université Paris-Sud, France

 Session Chair:

 Dr. Bao-Lian Su, Full Professor in Inorganic and Materials Chemistry, Director of the  
 Chemistry Department, Director of the Research Center for Nanomaterials Chemistry,  
 Director of the Laboratory of Inorganic Materials Chemistry, The University of Namur,  
 Belgium

 Title: Design of Ceramic-based Biomaterials for Bone Tissue Repair
 Dr. Toshiki Miyazaki, Associate Professor, Graduate School of Life Science and  
 Systems Engineering Kyushu Institute of Technology, Japan

 Title: Biomimetic Coating Techniques for Regenerative Medicine and Bone Tissue  
 Engineering
 Dr. Yuelian Liu, Assistant Professor, Department of Oral Implantology and  
 Prosthodontics, ?Academic Centre for Dentistry Amsterdam (ACTA), Amsterdam  
 University and VU University, the Netherlands

 Title: Progress and Perspectives for Cell Grafts and Therapy:Immobilization of Living  
 Microorganisms within Biocompatible Porous Matrices
 Dr. Bao-Lian Su, Full Professor in Inorganic and Materials Chemistry, Director of the  
 Chemistry Department, Director of the Research Center for Nanomaterials Chemistry,  
 Director of the Laboratory of Inorganic Materials Chemistry, The University of Namur,  
 Belgium

 Session Chair:

 Dr. Ailing Zhou, State University of New York at Binghamton Binghamton, USA

 Title: Sensors as Tools for Quantitation and Cytotoxicity Studies of Engineered  
 Nanomaterials
 Dr. Ailing Zhou, State University of New York at Binghamton Binghamton, USA

 Title: Nanoparticle-Directed Delivery of Diagnostic Imaging Agents and Therapeutic  
 Agents to Rabbit Atherosclerotic and Murine Breast Cancer Models
 Dr. Jodie L. Conyers, Assistant Director, Center for Translational Injury Research,  
 Director, Office of Biotechnology, Assistant Professor of Internal Medicine – Cardiology,  
 The University of Texas Health Science Center at Houston, USA

 Title: Electrochemical Methods for the Investigation of Bioaffinity Interaction
 Dr. V.V. Shumyantseva, Professor, Institute of Biomedical Chemistry, Russian  
 Academy of Medical Sciences, Russia

 Title: Metal-Filled Carbon Nanoparticles: Production and Growth Mechanism
 Dr. Kuo Chu Hwang, Professor, Department of Chemistry, National Tsing Hua  
 University, Taiwan

 Title: SPR Enhanced Size Dependent Photoluminescence from Silver Nanoparticles for  Biomedical Imaging
 Dr. Anatoliy O. Pinchuk, Assistant Professor, University of Colorado at Colorado  
 Springs, Physics and Energy Science, USA

 Session Chair:

 Dr. Tomas Landh, Director, Strategy and Sourcing & Principal Scientist, Diabetes  
 Research Unit, Novo Nordisk A/S, Denmark

 Title: Scouting Nano-technologies for Oral Delivery of Polypeptides
 Dr. Tomas Landh, Sourcing Director, Strategy and Sourcing & Principal Scientist,  
 Diabetes Research Unit, Novo Nordisk A/S, Denmark

 Title: Hydroxyapatite Nanoparticles Designed for Vaccine Delivery: Interactions with
 Cell Organelles and Intracellular Trafficking
 Dr. Michael Motskin, Multi-Imaging Centre, School of Biological Sciences,  
 Department of Physiology, Development and Neuroscience, Anatomy Building,  
 Downing Street, UK

 Title: Nanostructured Self-Assembled Amphiphile Nanoparticles for Drug Delivery
 Dr. Calum J. Drummond, Professor, FTSE FAICD FRACI CChem; Chief, CSIRO  
 Materials Science and Engineering; ARC Federation Fellow, CSIRO Molecular and  
 Health Technologies, Australia

 Title: Nanotechnology-enabled Drug Delivery: a Novel Approach for New Drug  
 Development
 Dr. Bai Xu, President and CEO, Suzhou Nanobiotechnology, Ltd., China

 Title: Enzymatically-Triggered Protein Nanocapsules for Intracellular Delivery
 Dr. Zhen Gu, University of California, Los Angeles (UCLA), USA

 Session Chair:

 Call for Host

 Title: Design and Prototyping of Miniaturized Human Tissue Bioreactors for Substance  
 Evaluation
 Dr. Uwe Marx, Chief Scientific Officer, ProBioGen, Germany

 Title: The Discovery and Utility of Cancer Antigens and Biomarkers Associating with
 Disease Progression and Response to Immunotherapy
 Dr. Robert C Rees, Tumour Biology, Research Director, The John van Geest Cancer
 Research Centre, UK

 Title: Aptamers for the Electrochemical Detection of Pathogens
 Dr. Marco Mascini, Professor of Analytical Chemistry, University of Firenze, Italy

 Title: Applications of Protein Chips in both Basic and Clinical Research
 Dr. Heng Zhu, Assistant Professor, Department of Pharmacology & High Throughput  
 Biology Center, Johns Hopkins University School of Medicine, USA

 Title: An array for Probing the Functions of Histone Modifications
 Dr. Sean Taverna, Assistant Professor, Pharmacology and Molecular Sciences,
 University of Virginia, USA

 Title: Suspension Bead Arrays for Plasma Proteomics
 Dr. Jochen M. Schwenk, Department of Proteomics, KTH - Royal Institute of
 Technology, AlbaNova University Center, Sweden

 Session Chair:

 Dr. Rong Mao, Co-Medical Director Molecular Genetics Section ARUP Laboratories,
 Assistant Professor of Pathology, University of Utah School of Medicine, USA

 Title: Clinical Validity of Using Microarray for Targeted DNA Sequence Capture Prior to  Next Generation Sequencing: Neurofibromatosis Type 1 (NF1) Gene as a Model
 Dr. Rong Mao, Co-Medical Director Molecular Genetics Section ARUP Laboratories,
 Assistant Professor of Pathology, University of Utah School of Medicine, USA

 Title: ChIP-seq Methodology (Solexa-Illumina, Roche)
 Dr. Matteo Cesaroni, Computational Biology & Bioinformatic Unit IEO, European  
 Institute of Oncology, Italy

 Title: Detecting Circulating Nucleic Acid Markers for Cancer Diagnosis
 Dr. Chiuan-Chian Chiou, Assistant Professor, Department of Medical Biotechnology  
 and Laboratory Science, Chang Gung University, Taiwan

 Title: Role of Molecular Diagnostics in the Programme for Global Elimination of  
 Lymphatic Filariasis
 Dr. S.L. Hoti, Scientist ‘F’ & Head, Microbiology and Immunology Unit, Vector Control  
 Research Centre (ICMR), India

 Session Chair:

 Dr. Peng Lee, Associate Professor of Pathology and Urology,New York University  
 School of Medicine,Director, Molecular Pathology,New York Harbor Healthcare System,  
 USA

 Title: "The New Era of "Acceleromics": The role of Physical Activity as Potential  
 Biomarker and Treatment Option".
 Dr. Martin Daumer, Scientific Director, Sylvia Lawry Centre, Munich, Germany

 Title: WNT Signaling Pathway in Metastatic and Androgen-independent Prostate  
 Cancer
 Dr. Peng Lee, Associate Professor of Pathology and Urology,New York University  
 School of Medicine,Director, Molecular Pathology,New York Harbor Healthcare System,  USA

 Title: Identification and Development of Serological Biomarkers for Autoimmune  
 Diseases Using Protein Chip Technology and Multiplex ELISA
 Dr. Xuhang Li, Assistant Professor of Medicine, Johns Hopkins University School of  
 Medicine, USA

 Session Chair:

 Dr. Alfred Lam, Foundation Chair Professor and Head of Pathology, Griffith University,  Australia

 Title: Braf Mutation: Application in Thyroid Cancer Diagnosis
 Dr. Alfred Lam, Foundation Chair Professor and Head of Pathology, Griffith University,  Australia

 Title: Role of Mucins in Cancer Diagnosis and Cancer Progression
 Dr. Subhash C. Chauhan, Associate Scientist, Cancer Biology Research Center,  
 USA

 Title: The Role of GAEC1 in the Molecular Diagnosis of Colorectal Cancer
 Dr. Vinod Gopalan, Research Fellow In Oncology, Cancer Molecular Pathology  
 Group, Department of Pathology, School of Medicine & Oral Health, Griffith University,  
 Australia

 Title: The Role of VEGF Polymorphism in Molecular Diagnosis of Thyroid Cancer
 Dr. Ali Salajegheh, Clinical Research Associate, School Of Medicine, Griffith
 University  - Gold Coast GH1Centre for Medicine and Oral Health, Australia

 Session Chair:

 Dr. H.Banerjee, Associate Professor, Biological and Pharmaceutical Sciences,  
 ElizabethCity State University, University of North Carolina, USA

 Title: Translating Genomic Technology into Clinical Practice: Oncotype DX, a Molecular  Assay for Breast Cancer Patients
 Dr. Chu Chang, Vice President, International - Asia Pacific, Genomic Health, Inc., USA

 Title: Application of Different Genomic and Proteomic Techniques for Identification of a  
 Diagnostic and Prognostic Biomarker for the Brain Cancer Glioblastoma Multiforme
 Dr. H.Banerjee, Associate Professor, Biological and Pharmaceutical Sciences,  
 ElizabethCity State University, University of North Carolina, USA

 Title: Molecular Staging of Colorectal Cancer: Ready for Prime Time?
 Dr. Jamie Murphy, Colorectal Surgical Registrar, Centre for Academic Surgery, Barts  and The London School of Medicine and Dentistry, UK

 Session Chair:

 Dr. Xiaohua (Tony) Hu, Chair, IEEE CS Bioinformatics & Biomedicine Steering
 Committee, USA

 Title: Genomic Information Tools for Privacy and Public Health Applications in Clinical  
 and Infectious Disease
 Dr. Jochen Kumm, Director, Biomathematics and Informatics
 Stanford Genome Technology Center, USA

 Title: Data Mining in? Bioinformatics: Mining, Modeling and Simulation of the  
 Biomolecular Network
 Dr. Xiaohua (Tony) Hu, Chair, IEEE CS Bioinformatics & Biomedicine Steering  
 Committee, USA

 Title: GeVaDSs- Support System for the Genetic Vaccine Design
 Dr. Piotr Lukasiak, Assist professor, Institute of Computing Science, Poznan  
 University of Technology, Poland

 Session Chair:

 Call for Host

 Title: Informatics Standardization for Personalized Genomics and Medicine
 Dr. Xitong Li, Sr Manager, Bioinformatics, Genomic Health, Inc., USA

 Title: Real-time in Vivo Cancer Diagnosis with a Microelectromechanical Systems  
 (MEMS) Based Handheld Dual-Axes Confocal Microscope
 Dr. Wibool Piyawattanametha, Departments of Applied Physics, Biology,  
 Electrical Engineering, Immunology, and Pediatrics, Stanford University, USA and  
 NECTEC, Thailand

 Title: ACTION Grid: European Research on Biomedical Informatics Towards  
 Nanomedicine
 Dr. Victor Maojo, Director, Biomedical Informatics Group, Universidad Politecnica de  
 Madrid, Spain

 Session Chair:

 Dr. Heiko Schroeder, Professor, Head of School, CS&IT, RMIT University, Australia

 Title: The Development of New Bio Imaging and Modelling Methods
 Dr. Richard Bayford, Principal Investigator, on the EPSRC project ; Professor in Bio- 
 modelling and informatics in the Bio-medical department, Middlesex University, UK

 Title: Application of Bioimaging Technology to Drug Research and Development
 Dr. Shintaro Nishimura, Senior Director, Bioimaging, Applied Pharmacological  
 Research Laboratories, Astellas Pharma Inc., Japan

 Title: High Speed Ab Initio Protein Structure Prediction
 Dr. Heiko Schroeder, Professor, Head of School, CS&IT, RMIT University, Australia

 Title:Immunological Bioinformatics for Vaccine Design
 Dr. Satarudra Prakash Singh, Faculty, Amity University Uttar Pradesh, India

 Session Chair:

 Dr. Vincent VanBuren, Assistant Professor, Texas A & M HSC College of Medicine,  
 USA

 Title: BioChips: Design from Theory
 Dr.B. Montgomery Pettittt, Cullen Professor, University of Houston, USA

 Title: New Bioinformatics Tools for Systems Biology
 Dr. Vincent VanBuren, Assistant Professor, Texas A & M HSC College of Medicine,
 USA

 Title: Engineering Analysis Methods in Understanding Biological Systems
 Dr. Hong Yue, Department of Electronic and Electrical Engineering, University of 
 Strathclyde, UK

 Title: Docking Studies and its Importance in Drug Design
 Dr. Suvarna.G.Kini, Associate Professor, Dept.Of Pharm. Chem., Manipal College of  
 Pharm.Sciences, Manipal University, Manipal. Karnataka, India

 Session Chair:

 Title: Silencing of Viral RNAs by Small Double-Stranded siDNA
 Dr. karin Moelling, Professor, University of Zurich, Institute of Medical Microbiolgy,
 Switzerland

 Title: Production of Novel Plant Metabolite-producing Cells using RNAi for Drug- 
 discovery Screening
 Dr. Fumihiko Sato, Professor, Kyoto University, Japan

 Title: Synthesis and Properties of siRNAs Modified with Aromatic Compounds
 Dr. Yoshihito Ueno, Associate professor, Department of Biomolecular Science,  
 Faculty of Engineering, Gifu University, Japan

 Title: Discovery of Small Non-coding RNAs inHuman Parasites Using Combined 
 Mass Sequencing and Computational Methods
 Dr. Xiaowei Sylvia Chen, Allan Wilson Centre for Molecular Ecology and Evolution,  
 Massey University, Palmerston North, New Zealand

 Session Chair:

 Dr. Tim Booth, Director, Viral Diseases Division, National Microbiology Laboratory,  
 Public Health Agency of Canada, Canadian Science Centre for Human and Animal  
 Health, Canada

 Title: From Stem Cells to Bone - an Application Combining mRNA-profiling and RNA  
 Interference in Drug Target Discovery/Validation)
 Dr. Yan Liu, Head, Tissue Culture & Stem Cell Laboratory, Biological Technologies,  
 Wyeth Pharmaceuticals, USA

 Title: RNA interference and Drug identification in Protozoan Parasites
 Dr. Moses Limo, Associate Professor,? Department of Biochemistry and Molecular  
 Biology, Egerton University, Kenya

 Title: Highly Facile Chemo-enzymatic Synthesis of Complex Sialic Acids
 Dr. Vinod Kumar Tiwari, Banaras Hindu University, India

 Session Chair:

 Dr. Dalia Cohen, CSO, Rosetta Genomics inc, USA

 Title: Mortalin siRNA and Cancer Therapeutics
 Dr. Renu Wadhwa, Head, Cell Proliferation Research Group Research Institute for  
 Cell Engineering (RICE), National Institute of Advanced Industrial Science & Technology  (AIST), Japan

 Title: Use of shRNA Library for Screening of Gene Targets for Selective Tumor Cell  
 Killing by Leaf Extract of Ashwagandha
 Dr. Sunil Kaul, Senior Research Scientist,National Institute of Advanced Industrial  
 Science & Technology (AIST), Japan

 Title: CARF siRNA Induces Apoptosis in Cancer Cells
 Dr. Caroline Cheung, Cell Proliferation Research Group, Research Institute for Cell
  Engineering, National Institute of Advanced Industrial Science & Technology (AIST),  
 Japan

 Session Chair:

 Dr. Yu Shen, Senior Group Leader siRNA Therapeutics Abbott Laboratories, USA

 Title: A Novel Assembly Approach for Safe in vivo Targeted Delivery of siRNA
 Dr. Huixin He, Assistant Professor of Chemistry, Nanoscience and Nanotechnology  
 Laboratory, Rutgers University, USA

 Title: Non-viral Delivery Technology for Small Interfering RNAs
 Dr. Xudong Yuan, Assistant Professor, Department of Pharmaceutical Sciences,  
 Long Island University, USA

 Title:Viral Vector-mediated Delivery of Small RNAs to the Liver
 Dr. Jin-Wook Kim, Department of Internal Medicine, Seou National University  
 Bundang Hospital, South Korea

 Session Chair:

 Dr. Ba-Bie Teng, Associate Professor of Molecular Medicine, Center for Human  
 Genetics, Brown Foundation Institute of Molecular Medicine, University of Texas Health  
 Science Center at Houston, USA

 Speaking Opportunity Available

 Title: Combinatorial Control of Suicide Gene Expression by Tissue-specific Promoter  
 and microRNA Regulation for Cancer Therapy
 Dr. Chunxiao Wu, Research Scientist, Institute of Bioengineering and
 Nanotechnology, Singapore

 Session Chair:

 Dr. Pran K. Datta, Associate Professor, Division of Surgical Oncology, Department of  Cancer Biology, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medial Center,  USA

 Title: Targeting TGF-beta Signaling In Liver Metastasis of Colon Cancer
 Dr. Bixiang Zhang, Associate Professor, Division of Hepatic Surgery, Department of  
 Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and  
 Technology, China

 Title: Evidence that Normoxically Expressed Hypoxia Inducible Factor 1- apha Is  
 Involved in the Resistance Acquisition of Arsenic Trioxide in Human Hepatoma Cells
 Dr. Tsan-Zon Liu, Consultant/professor, Taipei Medical University Hospital, Taiwan

 Title: Reversal of Multi-drug Resistance Measured on one Single Leukemic Cell  
 Selected in?a Microfluidic Zellchip
 Dr. Paul C.H. Li, Associate Professor, Department of Chemistry, Department of  
 Molecular Biology and Biochemistry, Simon Fraser University, Canada

 Title: Antimetastatic Role of Smad4 Signaling in Colorectal Cancers
 Dr. Pran K. Datta, Associate Professor, Division of Surgical Oncology, Department of  Cancer Biology, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medial Center,  USA

 Session Chair:

 Dr. Masaharu Seno, Professor, Laboratory of Nano-Biotechnology, Department of  
 Medical and Bioengineering Science, Graduate School of Natural Science and  
 Technology, Okayama University, Japan

 Title: CD44 as a Candidate Biomarker Commonly Expressed in Gliomas
 Dr. Masaharu Seno, Professor, Laboratory of Nano-Biotechnology, Department of  
 Medical and Bioengineering Science, Graduate School of Natural Science and  
 Technology, Okayama University, Japan

 Title: Structure-Activity Relationships and Cancer-Cell Selective Toxicity of Novel  
 Inhibitors of Glioma-Associated Oncogene Homolog 1 (Gli1)-Mediated Transcription
 Dr. Naoaki Fujii, Assistant Member, Department of Chemical Biology and  
 Therapeutics, St Jude Children's Research Hospital, USA

 Title: Myeloperoxidase-mediated Lipoprotein Carbamylation as a Mechanistic Pathway  for Atherosclerotic Vascular Disease
 Dr. Sanjeev Sirpal, University of Miami School of Medicine, Miami, FL 33101, USA

 Title: Lipocalin 2 Promotes Breast Cancer Progression:  Mechanistic Studies and
 Clinical Implications
 Dr. Jiang Yang, Postdoctoral Fellow, Moses Laboratory, Vascular Biology Program,  
 Children's Hospital Boston, USA

 Session Chair:

 Call for Host

 Title: HLA-G: implications in Oncology
 Dr. Shang-mian Yie, Professor and Director of Core Laboratory?Sichuan Academy of  Medical Sciences, China

 Session Chair:

 Call for Host

 Title: Cisplatin-Liposomes Targeting Endothelial Cells in Tumor Angiogenesis
 Dr. Masaharu Seno, Professor, Okayama University, Japan

 Title: Potentially Cure More Patients with Lung Cancer with Precisive Radiotherapy
 Dr. Guangying Zhu, Professor of Peking University, Vice director of Department of  
 Radiation Oncology, Beijing Cancer Hospital, China

 Title: Exploiting Multimodal in Vivo Imaging for Targeted Cancer Treatment in
 Preclinical Animal Models
 Dr. Dawen Zhao, Assistant Professor, Department of Radiology, University of Texas
 Southwestern Medical Center, USA

 Title: New Biotherapeutic Approach to Rare Tumors
 Dr. Giovannella Palmieri, Dipartimento di  Endocrinologia ed Oncologia Molecolare  e Clinica, Università Degli Studi di Napoli Federico II, Facoltà Di Medicina e Chirurgia,  
 Italy

 Title: Cancer drug development: where are we then and now?
 Dr. Shudong Wang, University of Nottingham, UK

 Title: Targeting the MicroRNA in the Treatment of Adult T-cell Leukemia
 Dr. Mariko Tomita, Assistant professor, Division of Molecular Virology and Oncology,  Graduate School of Medicine, University of the Ryukyus, Japan

 Title: Hypoxia-inducible Factor-1α is Required For Maintenance of Lymphoma Cancer  Stem Cells
 Dr. Yin Wang, Assistant Professor, Section of General Surgery, Department of  
 Surgery, University of Michigan, USA

 Title: Nutraceuticals: Targeted Therapy for Intrinsic Brain Tumours
 Dr. Harcharan Kaur (Bali) Rooprai, Reader in Scientific Basis of Complementary
 Medicine, Neuro-oncology Group, Department of Natural Sciences, School of Health
 and Social Sciences, Middlesex University, UK

 Session Chair:

 Dr. Thomas Felzmann, CEO, Trimed Biotech GmbH, Associate Professor of  
 Immunology, Medical University Vienna, Austria

 Title: Antigen-specific Cancer Immunotherapeutics: Novel Approach for Cancer  
 Treatment
 Dr. Aung Myo, Clinical Development Manager, Clinical R&D, International Cancer  
 Immunotherapeutics(ASCI), GlaxoSmithKline Biologicals, Singapore

 Title: Clinical Phase II Development of a Novel Dendritic Cell Based Cancer Vaccine  
 Technology Platform in Patients with Metastatic Renal Cell Carcinoma
 Dr. Thomas Felzmann, CEO, Trimed Biotech GmbH, Associate Professor of  
 Immunology, Medical University Vienna, Austria

 Title: Novel Approaches to Cancer Therapeutic Vaccine
 Dr. Jaulang Hwang, Professor, Institute of Molecular Biology, Academia Sinica,  
 Taiwan

 Title: Tumor Vaccine Like Treatment Effect of a New Light Activated Drug Therapy
 Dr. Sy-Shi Wang, VP Clinical Development, Light Sciences Oncology, Inc., USA

 Session Chair:

 Dr. Yiwen Li, Senior Group Leader, Immunology, ImClone Systems, Eli Lilly &  
 Company, USA

 Title: Development of an Anti-FLT3 Antibody for Leukemia Therapy
 Dr. Yiwen Li, Senior Group Leader, Immunology, ImClone Systems, Eli Lilly &  
 Company, USA

 Title: Microarray Technology to Discover which Microrna are Important under What  
 Conditions
 Dr. Tsykin Anna, Senior Research Associate, School of Mathematics, University of  
 Adelaide, North Terrace, Adelaide, South Australia, Australia

 Session Chair:

 Call for Host

 Speaking Opportunity Available

 Title: Ceramide 1-phosphate is a Novel Regulator of Cell Homeostasis and Migration.  
 Possible role in Tumorigenesis.
 Dr. Antonio Gómez-Mu?oz, Professor, Department of Biochemistry and
 Molecular Biology, University of the Basque Country, Spain

 Speaking Opportunity Available

 Title: Molecular Basis of Multidrug Resistance in Cancers
 Dr. Frouzandeh Mahjoubi, Department of Clinical Genetics, National Institute of  
 Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran

 Title: Molecular Evolution in Bladder Cancer Opportunities for Diagnosis, Prognosis  
 and Treatment
 Dr. Sarel Halachmi, Deaprtment of Urology, Bnai Zion Medical Center, Israel

 Session Chair:

 Call for Host

 Title: Therapeutic Single-Chain T Cell Receptors
 Dr. Matthias Theobald, Professor of Hematology, Department of Hematology and  
 Van Creveld Clinic, University Medical Center Utrecht, The Netherlands

 Title: PUMA as a Potent Effector in Cancer Gene Therapy
 Dr. Haili Qian, Associate professor, State Key Laboratory of Molecular Oncology of  
 Chinese Academy of Medical Sciences, China

 Title: Elucidating the Potential Efficacy of Indole Derivatives in Prevention of Cancer  
 Cell Growth: Development of New Strategies for Cancer Prevention and Treatment
 Dr. Fuad Fares, Professor, Faculty of Science, University of Haifa, Haifa, and  
 Department of Molecular Genetics, Carmel Medical Center, Israel

 Session Chair:

 Call for Host

 Title: Donor Cell Infusions as Anti-cancer Therapy following Allogeneic Bone Marrow  
 Transplantation
 Dr. Yener Koc, Professor, Member of EBMT, CIBMTR, ISCT, ASH, Turkey

 Title: The Importance of Human Bladder Cancer Cell Line In the Research of New  
 Therapeutic Approach
 Dr.Rosário Pinto Leite, Centro Hospitalar de Trás-os-Montes e Alto Douro Vila Real,  Portugal

 Session Chair:

 Call for Host

 Title: Genome-wide Mapping of Transcription Factor STAT Binding and Epigenetic  
 Modifications in CD4+ T Cells
 Dr. Lai Wei, Lymphocyte Cell Biology Section, Molecular Immunology and  
 Inflammation Branch, NIAMS, NIH, USA

 Title: TBD
 Dr. Joseph Rosenthal, Principal Investigator, Pediatric Bone Marrow
 Transplantation, City of Hope, USA

 Title: Induction of HSV-1 CD8+ mmunity Using Recombinat IL-15 and IL-21
 Dr. Luiz Rodrigues, Adjunct Professor, Curso de Farmácia e Mestrado em  
 Nanociências-UNIFRA, Brazil

 Session Chair:

 Title: From Vision to Reality-From Genomics Targets to Antibody Cancer Therapeutics Dr. Aya Jakobovits, Executive Vice President and Head, Research & Development,  Agensys, USA

 Title: The ZEBRA trans-activator of Epstein-Barr Virus (EBV): A Major Antigen for the  Control of EBV Diseases
 Dr. Emmanuel Drouet, Professeur de Microbiologie et Immunologie, Faculté de  Pharmacie, Grenoble, Université Joseph Fourier, Grenoble I, France

 Title: Immunocytochemical Study of Helicobacter Pylori
 Dr. Viacheslav Kravtsov, Professor, the Nikiforov Russian Center of Emergency  and radiation Medicine EMERCOM of Russia, Russia

 Title: Protein Array Based Analysis of Antibody Specificity within the Human Protein  Atlas
 Dr. Peter Nilsson, Associate Professor, Department of Proteomics, School of  Biotechnology, KTH – Royal Institute of Technology, Albanova University Center,  Sweden

 Title: Efficient Selection of Human McAbs Using Display Technology
 Dr. Xiao-Ling Zhao, Associate Professor, Institute of Health and Environmental  
 Medicine, China

 Title: Cost-Effectiveness of Predictive Testing for HER2 Overexpression in the Breast  
 Cancer Setting – A life-long Markov Model  from a Swiss Perspective
 Dr. Patricia Blank, Institute of Social and Preventive Medicine, Medical Economics,  
 University of Zurich, Switzerland

 Session Chair:

 Dr. Hua.Yang, Associate Director, Head of Discovery DMPK & PKPDE Modeling,  
 Millennium Pharmaceuticals, Inc, USA

 Title: ImClone's Innovative Monoclonal Antibody Portfolio: Global Clinical  
 Development
 Dr. Larry Witte, Senior Vice President and Head of Research at ImClone Systems
 International GmbH, Germany

 Title: Development of an Automated Method for Monoclonal Antibodies Purification  
 and Analysis
 Dr. Gurmil Gendeh, Corporate Market Development Manager, Dionex Corporation,  USA

 Speaking Opportunity Available

 Title: Development of Therapeutic Antibody with Multiple Effects for Treatment of  
 Cancer and Other Disorders
 Dr. Yan Wu, Group Leader, Department of Antibody Technology, ImClone Systems, a  wholly-owned subsidiary of Eli Lilly and Company, USA

 Title: Preclinical Discovery and Development of Therapeutic Antibodies: DMPK  
 Perspectives
 Dr. Hua Yang, Associate Director, Head of Discovery DMPK & PKPDE Modeling,  
 Millennium Pharmaceuticals, Inc, USA

 Title:Development of Novel anti-IL-6 Biologics for Inflammatory Diseases
 Dr. Charles J. Malemud, Professor of Medicine & Anatomy, Case Western Reserve  University, School of Medicine, Cleveland, Ohio, USA

 Title: Monoclonal Antibody F77 Defines a Novel Cell Surface Structure and Reverses  
 the Phenotype of Human Prostate Cancer
 Dr. Geng Zhang, Postdoc researcher, Pathology and Lab Medicine University of  
 Pennsylvania, USA

 Title:Boosting Immune 'Killer Cells,' Increases Antibody Effectiveness Against Cancer
 Dr. Mohammad Ashkan Moslehi, Paediatrician, Registrar of Shiraz University of  
 Medical Sciences Shiraz, Iran

 Title: Immunization Therapies Toward Tauopathies
 Dr. Hiroki Takeuchi, Department of Neurology, Kyoto University Graduate School of  Medicine, Center for iPS Cell Research and Application (CiRA), Kyoto University,  
 Japan

 Session Chair:

 Dr. Thomas Vorup-Jensen, Associate Professor, Biophysical Immunology  
 Laboratory, Department of Medical Microbiology & Immunology, Aarhus University,  
 Denmark

 Title: Soluble Beta-2 Integrins as Markers for Chronic Inflammation Disorders
 Dr. Thomas Vorup-Jensen, Associate Professor, Biophysical Immunology  
 Laboratory, Department of Medical Microbiology & Immunology, Aarhus University,  
 Denmark

 Title: Molecular Imaging of Atherosclerotic Plaques
 Dr. Christian M.  Matter, Senior scientist, University of Zurich. Institute of  
 Physiology, Switzerland

 Title: Role of Salivary IgA Antibody against Surface Protein Antigen of Streptococcus  
 Mutans in Diagnosis and Preventive Treatment
 Dr. Hidenobu Senpuku, Laboratory Head, Department of Bacteriology, National  
 Institute of Infectious Disaesaes, Japan

 Title: Plasmonic Nanosensors for Label-Free Bio-Detection
 Dr. Lai-Kwan Chau, Professor, Department of Chemistry and Biochemistry, National  Chung Cheng University, Taiwan

 Title: Synaptic Structure and Function Affected by Various Antibodies in  
 Neuromuscular Transmission
 Dr. Masaharu Takamori, Director, the Neurological Center at Kanazawa-Nishi  
 Hospital, Professor Emeritus, Kanazawa University, Japan

 Title: Development of a Genetically Fused  Recombinant Antibody Fragment–Green 
 Fluorescent Protein Conjugate for  Rabies  Virus  Diagnosis
 Dr. Mohamed Mousli, Senior Research Scientist, Institut Pasteur de Tunis,  
 Laboratoire Immuno-Biotechnologie, Tunisia

 Title:Diagnosis of Thrombotic State by Immunoassay Using Several Monoclonal  
 Antibodies
 Dr. Hideo Wada, Professor, Department of Laboratory Medicine, Mie University  
 School of Medicine, Japan

 Speaking Opportunity Available

 Title: Diagnostic Markers for Malignant Pleural Mesothelioma: Serum Antibody
 against Antigens Recognized by Antibodies Produced from Tumor Infiltrating B cells
 Dr. Kosei Yasumoto, Professor, Dr. ShIigematsu Yoshiki, 2nd department of
 surgery, University of occupational and environmental health, Japan

 Speaking Opportunity Available

 Speaking Opportunity Available

 Session Chair:

 Dr. Guoping Zheng, NHMRC Research Fellow, Centre for Transplantation and  
 Renal Research, Sydney, Australia

 13:30-13:50

 Title: MIDGE Vector System for Vaccine Development
 Dr. Matthias Schroff, CEO, MOLOGEN AG, Berlin, Germany

 13:50-14:10

 Speaking Opportunity Available

 14:10-14:30

 14:30-14:50

 14:50-15:10

 Title: Utilizing Cytokines as Immunological Adjuvants to Enhance Immune Responses  Generated by DNA Vaccine
 Dr. Christine Hartoonian, Department of Pharmaceutical Biotechnology, Faculty of  Pharmacy, Tehran University of Medical Sciences, Iran

 Session Chair:

 Call for Host

 Title: Leishmania Amastigotes Proteins Induced Psoriasis Remission
 Dr. Jose O’Daly, CSO, Astralis LTD, USA

 Title: Baculovirus P. falciparum and P. vivax MSP1p19 Malaria Vaccine Candidates:  
 Unparalleled Preclinical Validation and Clinical Development
 Dr. Shirley Longacre, Director of Recherche, CNR, Pasteur Institute, France

 Title: HPV Prophylactic and Therapeutic Vaccine
 Dr. Woong-Shick Ahn, President of Korean Photodynamic Association,  
 Department of OB&GYN, College of Medicine,The Catholic University of Korea, Korea

 Title: Novel vaccine against Helicobacter Pylori Infections
 Dr. Eleonora Altman, Senior Research Officer, Institute for Biological Sciences,  
 National Research Council of Canada, Canada

 Title: Host and Mycobacterium Factors Influencing Tuberculosis Outcomes
 Dr. José R. Lapa e Silva, Professor of Pulmonary Medicine and mmunology,  
 Federal University of Rio de Janeiro and Weill Medical College of Cornell University,  
 Brazil and USA

 Title: Parasite and Leukocyte Sequestration During Experimental Cerebral Malaria
 Dr. Carla Claser, Laboratory of Malaria Immunobiology - Laurent Renia, Singapore  Immunology Network, Singapor

 Title: Development of Streptococcus Subunit Vaccine
 Dr. Chun-Yen Chu, Associate professor, Graduate Institute of Animal Vaccine  
 Technology, National Pingtung University of Science and Technology, Taiwan

 Title: The Adjuvant Effects of Interleukin-18 and CpG ODN in Vaccination against  
 Japanese Encephalitis virus Infection
 Dr. Hso-Chi Chaung, Associate Professor, National Pingtung University of Science  
 and Technology, Taiwan

 Session Chair:

 Call for Host

 Title: AGE1.Cell Lines – Novel Cell Substrates For Vaccine Manufacturing
 Dr. Volker Sandig, VP, Cell & Vector Biology, ProBioGen, Germany

 Title: Strain Development Technology for Amino Acid Production in Genomic Era
 Dr. Masato Ikeda, Professor, Shinshu University, Japan

 Title: Anti-inflammatory and Anti- oxidatve Interventions in Cellular Models of Diabetic  
 Vascular Dysfunctions
 Dr. Zhihong Yang, Professor, Laboratory of Vascular Biology, Department of  
 Medicine, Division of Physiology, Faculty of Science, University of Fribourg, Switzerland

 Session Chair:

 Dr. Joseph Bertolini, R&D Manager, CSL Bioplasma, Australia

 Title: Maunfacturing Scale Protein Chromatography
 Dr. Joseph Bertolini, R&D Manager, CSL Bioplasma, Australia

 Title: Epigenetic Strategies in Anticancer and Antimetastatic Therapy
 Dr. Moshe Szyf, Professor, McGill University, Canada

 Speaking Opportunity Available

 Title: Biotechnology Development of Germinated Brown Rice in Taiwan
 Dr. Ling Ling Yang, Endowed Professor of Taipei Medical University; Committee  
 Chinese Medicine and Pharmacy, Department of Health, R.O.C.; Committee Nedical  
 Science Education, Minitery of Education, Taiwan

 Session Chair:

 Dr. Donald F. Gerson, President, COO Business, Celltrion, Inc., Korea

 Title: Large-Scale Manufacturing of Protein Biopharmaceuticals in Mammalian Cell  
 Culture
 Dr. Donald F. Gerson, President, COO Business, Celltrion, Inc., Korea

 Speaking Opportunity Available

 Title: Challenges in Developping Anti-Cancer Vaccines.
 Dr. Jean-Pierre Abastado, Principal Investigator, Singapore Immunology Network,  
 Singapore

 Session Chair:

 Call for Host

 Title: MicroRNAs in B-cell Malignancies
 Dr. Aldo Roccaro, Instructor of Medicine, Harvard Medical School, USA

 Title: Novel Liposomes for in Vivo Delivery of siRNA for Cancer Treatment
 Dr. Nigel McMillan, Deputy Director and Principal Research Fellow, Associate  
 Professor, UQ Diamantina Institute for Cancer, Immunology and Metabolic Medicine;  
 University of Queensland, Australia

 Title: A Promising Potential of siRNA as a Novel Antiviral Agent for Human
 Enteroviruses
 Dr. Heuiran Lee, Associate Professor, Director of Research Institute for  
 Biomacromolecules, Department of Microbiology, Research Institite for  
 Biomacromolecules, University of Ulsan College of Medicine, Korea

 Speaking Opportunity Available

 Session Chair:

 Dr. Haidong Tan, Associate Professor, Group 1816, Division of Biotechnology, DICP,  
 CAS, Dalian, China

 Speaking Opportunity Available

 Title: Design a Winning Stratey for Downstream Process Development--Bayer's  
 Innovative Approach
 Dr. Daniel Auriel, Head of Innovation Management, Bayer Technology Service,  
 China

 Title: TBD
 Dr. Eun-Kyu Lee, Professor, Bioprocessing Research Laboratory, Department of  
 Chemical Engineering, Hanyang University, Korea

 Session Chair:

 Dr. Frank Grams, Global Business Development Director, Roche Pharma Partnering  Asia, USA

 Title: Science and Technology Discovery to Meet Global Health Needs
 Dr. Carol A. Dahl, Director Global Health Discovery, Bill & Melinda Gates Foundation,  USA

 Title: Pharma Partnering in Asia: The Roche approach
 Dr. Frank Grams, Global Business Development Director, Roche Pharma Partnering  Asia, China

 Title: Opportunities & Challenges of Bio-Venture In China
 Mr. Hang Xu, Partner, SAIF Partners, China

 Title: Internationalisation of Biomedical business models - Opportunities for China
 Ms. Hui Hsing Ma, General Partner,TVM Capital, Germany

 Session Chair:

 Dr. Frank Grams, Global Business Development Director, Roche Pharma Partnering  Asia, USA

 Title: Enhancing Pharmaceutical R&D Innovation through External Partnership
 Dr. Yangde Chen, China R&D, sanofi-aventis, Beijing, China

 Title: TBD
 Dr. Larry Glass, CEO(US), Neuren Pharmaceuticals, USA

 Title: Tracking the Current Rise of Chinese Pharmaceutical Bionanotechnology
 Dr. Patrick Herron, Research Analyst & Technologist, Kimberly J. Jenkins Chair for  
 New Technologies in Society, Duke University, USA